Search research articles
Contact Us
Filters
Showing results (171-180 of 183) with videos related to
Page
of 19
Sort By:
Plos Pathogens
|
August 7, 2018
The Epstein Barr virus circRNAome
Nathan Ungerleider, Monica Concha, Zhen Lin, et al.
BMC Genomics
|
October 18, 2005
EST analysis in Ginkgo biloba: an assessment of conserved developmental regulators and gymnosperm specific genes
Eric D Brenner, Manpreet S Katari, Dennis W Stevenson, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 5, 2020
Translation of the intrinsically disordered protein α-synuclein is inhibited by a small molecule targeting its structured mRNA
Peiyuan Zhang, Hye-Jin Park, Jie Zhang, et al.
Journal of Medicinal Chemistry
|
October 11, 1996
Peptidomimetic inhibitors of herpes simplex virus ribonucleotide reductase with improved in vivo antiviral activity
N Moss, P Beaulieu, J S Duceppe, et al.
Journal of Medicinal Chemistry
|
March 3, 1999
Phosphotyrosine-containing dipeptides as high-affinity ligands for the p56lck SH2 domain
M Llinaś-Brunet, P L Beaulieu, D R Cameron, et al.
Journal of Virology
|
December 21, 2018
Comparative Analysis of Gammaherpesvirus Circular RNA Repertoires: Conserved and Unique Viral Circular RNAs
Nathan A Ungerleider, Vaibhav Jain, Yiping Wang, et al.
Medrxiv : the Preprint Server for Health Sciences
|
December 11, 2023
SARS-CoV-2 Orphan Gene ORF10 Contributes to More Severe COVID-19 Disease
Jeffrey Haltom, Nidia S Trovao, Joseph Guarnieri, et al.
Molecular Biology and Evolution
|
October 15, 2025
Importance of De Novo Gene Evolution to Emerging Viral Threats: The ORF10 Strain-Restricted Orphan Gene of SARS-CoV-2 Promotes Pathogenesis
Jeffrey A Haltom, Nidia S Trovao, Joseph W Guarnieri, et al.
Journal of Medicinal Chemistry
|
May 29, 1999
Ligands for the tyrosine kinase p56lck SH2 domain: discovery of potent dipeptide derivatives with monocharged, nonhydrolyzable phosphate replacements
P L Beaulieu, D R Cameron, J M Ferland, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 29, 2008
Pyrazinoindolone inhibitors of MAPKAP-K2
D R Goldberg, Y Choi, D Cogan, et al.
Page
of 19
Search research articles
Search
Showing results (171-180 of 183) with videos related to
Sort By:
Page
of 19
Plos Pathogens
|
August 7, 2018
The Epstein Barr virus circRNAome
Nathan Ungerleider, Monica Concha, Zhen Lin, et al.
BMC Genomics
|
October 18, 2005
EST analysis in Ginkgo biloba: an assessment of conserved developmental regulators and gymnosperm specific genes
Eric D Brenner, Manpreet S Katari, Dennis W Stevenson, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 5, 2020
Translation of the intrinsically disordered protein α-synuclein is inhibited by a small molecule targeting its structured mRNA
Peiyuan Zhang, Hye-Jin Park, Jie Zhang, et al.
Journal of Medicinal Chemistry
|
October 11, 1996
Peptidomimetic inhibitors of herpes simplex virus ribonucleotide reductase with improved in vivo antiviral activity
N Moss, P Beaulieu, J S Duceppe, et al.
Journal of Medicinal Chemistry
|
March 3, 1999
Phosphotyrosine-containing dipeptides as high-affinity ligands for the p56lck SH2 domain
M Llinaś-Brunet, P L Beaulieu, D R Cameron, et al.
Journal of Virology
|
December 21, 2018
Comparative Analysis of Gammaherpesvirus Circular RNA Repertoires: Conserved and Unique Viral Circular RNAs
Nathan A Ungerleider, Vaibhav Jain, Yiping Wang, et al.
Medrxiv : the Preprint Server for Health Sciences
|
December 11, 2023
SARS-CoV-2 Orphan Gene ORF10 Contributes to More Severe COVID-19 Disease
Jeffrey Haltom, Nidia S Trovao, Joseph Guarnieri, et al.
Molecular Biology and Evolution
|
October 15, 2025
Importance of De Novo Gene Evolution to Emerging Viral Threats: The ORF10 Strain-Restricted Orphan Gene of SARS-CoV-2 Promotes Pathogenesis
Jeffrey A Haltom, Nidia S Trovao, Joseph W Guarnieri, et al.
Journal of Medicinal Chemistry
|
May 29, 1999
Ligands for the tyrosine kinase p56lck SH2 domain: discovery of potent dipeptide derivatives with monocharged, nonhydrolyzable phosphate replacements
P L Beaulieu, D R Cameron, J M Ferland, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 29, 2008
Pyrazinoindolone inhibitors of MAPKAP-K2
D R Goldberg, Y Choi, D Cogan, et al.
Page
of 19